Clinical Trial Results:
A Multi-Centre, Randomised, Double-Blind, Parallel-Group, Placebo- and Active-
Controlled, Flexible Dose Study Evaluating the Efficacy, Safety and Tolerability of
Extended-Release Bupropion Hydrochloride (150mg - 300mg once daily), Extended-
Release Venlafaxine Hydrochloride (75mg - 150mg once daily) and Placebo in Subjects with Major Depressive Disorder.
Summary
|
|
EudraCT number |
2004-003803-19 |
Trial protocol |
SE |
Global completion date |
14 Jun 2005
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
16 Feb 2016
|
First version publication date |
08 Nov 2014
|
Other versions |
|
Summary report(s) |
101497-Clinical-Study-Result-Summary |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.